• Kit Solutions

    Kit Solutions

    AntBio offers mIHC kits, organoid culture kits, conventional and One-step ELISA assay kits, RNA/DNA/protein interaction kits, etc.

  • Cytokine Solutions

    Cytokine Solutions

    AntBio provides related cytokines of different cell types (organoids, stem cells, immune cells, etc.) with high purity and high activity verification

  • Target Protein Solutions

    Target Protein Solutions

    AntBio offers high performance target proteins in different research areas (antibody drugs, ADC drugs, CAR-T, small molecule drugs, etc.)

  • Loading Control

    Loading Control

    AntBio offers reliable and high-quality loading control antibodies, essential for accurate normalization in Western blotting and other protein quantification assays.

Promotion 1:

20% off for 5+ items

Enjoy 20% discount on 5 or more items storewide including OneStep ELISA Kits, mIHC Kits, IHC antibodies, Organoid Culture Kits, PTMs antibodies and so on.

Promo Period: 1 September 2025 to 31 September 2025

View Promotions

Promotion 2:

Cytokines Buy 3 Get 1 Free

  • Hig h Purity
  • High Activity
  • Customizable Solutions
  • Strict Quality Control
  • Wide Application

Promo Period: 1 September 2025 to 31 October 2025

View Promotions

Promotion 3:

20% off on label/reference antibodies

High specificity and affinity
High sensitivity
High stability
Low batch-to-batch variation
Multiple application validations

Promo Period: 1 September 2025 to 31 October 2025

View Promotions

Promotion 4:

Anti-Rabbit and Mouse HRP-DAB IHC detection kit (2-step), S0C2011

Promotion price: $120
Biotin-free polymerization technology eliminates endogenous biotin background
Polymer HRP has higher sensitivity and stability

Promo Period: 1 September 2025 to 31 October 2025

View Promotions
bg

About Us

AntBio - Life Science Research Tools

AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.

About Us

50k

Happy Clients

100k

Products

70+

Doctor/Expert

20+

Life Science Experience

STARTER Pathological IHC Antibodies Facilitate Research on APOE+ Tumor-Associated Macrophages in the Hepatocellular Carcinoma Immune Microenvironment

STARTER Pathological IHC An...

The study titled APOE deficiency triggers anti-tumour activity of macrophages in liver cancer was published in the Nature sub-journal Cancer Gene Therapy. Led by Xintong Xia from Zhejiang Chinese Medical...

STARTER Pathological IHC An...

The study titled APOE deficiency triggers anti-tumour activity of macrophages in liver cancer was published in the Nature sub-journal Cancer...

View Details
Dual-Defect Nitrogen-Rich Carbon Nitride-Based Heterostructural Nanocatalyst: A Groundbreaking Study on Remodeling the Tumor Immune Microenvironment

Dual-Defect Nitrogen-Rich Carbon Nitr...

In the field of malignant bone tumor treatment, the efficacy of immunotherapy is often limited by issues such as low tumor immunogenicity, insufficient immune infiltration, and an immunosuppressive microenvironment. A...

Dual-Defect Nitrogen-Rich Carbon Nitr...

In the field of malignant bone tumor treatment, the efficacy of immunotherapy is often limited by issues such as low...

View Details
Bile Acid Receptor FXR Regulating Intestinal Epithelial Ferroptosis

Bile Acid Receptor FXR Regulating Int...

Neonatal Necrotizing Enterocolitis (NEC) is a common life-threatening intestinal emergency in preterm infants. The incidence rate of NEC in very low birth weight infants worldwide is approximately 7%, and the...

Bile Acid Receptor FXR Regulating Int...

Neonatal Necrotizing Enterocolitis (NEC) is a common life-threatening intestinal emergency in preterm infants. The incidence rate of NEC in very...

View Details
How Does CCR8+Treg Targeted Therapy Overcome PD1 Resistance?

How Does CCR8+Treg Targeted Therapy O...

Recently, Journal of Thoracic Oncology (IF 20.8) published a groundbreaking study on lung cancer immunotherapy titled "Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in...

How Does CCR8+Treg Targeted Therapy O...

Recently, Journal of Thoracic Oncology (IF 20.8) published a groundbreaking study on lung cancer immunotherapy titled "Selective Depletion of CCR8+Treg...

View Details